SwissExtract AG was granted the cultivation and production license for the "Züri Can" project by the Federal Office of Public Health on March 21, 2023, as we meet the strict requirements for cultivating the plants. As the main supplier, we are initially cultivating around 2,500 cannabis plants for the city of Zurich on an area of ​​more than 1,000 square meters in a state-of-the-art greenhouse.

For the study, three cannabis strains with ideal cannabinoid and terpene profiles were selected: one with the maximum permitted THC content of 20%, one in the mid-range of 12–13%, and one with a very balanced content of 10% THC and 10% CBD. The first deliveries arrived at the end of August 2023. Further studies with public and university institutions as well as private project operators started later that same year. SwissExtract AG will again produce the study cannabis for some of these projects.

To mark the launch of sales at Züri Can, the project team and Stefan Strasser answer various questions and provide an insight into the Zurich city cannabis study.

To the YouTube video Züri Can

Study participants can find additional information about the project at the following link:

Züri Can – Responsible Cannabis – City of Zurich

The cannabis pilot project "Grashaus Projects" is a collaboration between ISGF and Sanity Group Switzerland AG. Together, they are committed to cannabis research and thus make a valuable contribution to the future of Swiss drug policy, which prioritizes consumer health, education, and youth protection.

The Swiss Institute for Addiction and Health Research (ISGF), an institute associated with the University of Zurich, is conducting the scientific study.

The practical implementation of the sale and purchase of the products is organized by Sanity Group Switzerland AG, a Swiss subsidiary of Sanity Group GmbH from Germany. Sanity Group's interest lies in promoting research on cannabis.

The Federal Office of Public Health (BAG) has approved the cannabis products for this study.

SwissExtract AG is the main supplier for the "Grashaus Projects" pilot project, providing various products such as flowers, hashish, vapes, and edibles. Our cultivation company places high demands on quality, sustainability, traceability, and Swissness for the production of its BioSuisse-certified cannabis. To guarantee this high product quality, SwissExtract manages the entire value chain under one roof, from planting the seeds to the finished extract. As part of this pilot project, SwissExtract AG's cannabis products will be sold starting in early December in the first specialty shop for legal, THC-containing products in the canton of Basel-Landschaft.

More information at: www.grashausprojects.ch

The Zurich-based association Swiss Cannabis Research launched the largest cannabis study in Switzerland on May 2, 2024 in the canton of Zurich and plans to conduct it with around 7,500 participants over the next five years together with an independent research team from the University of Zurich and the KOF/ETH economic research institute.

Study participants will now have the opportunity to consume cannabis for recreational purposes within a regulated framework and to legally purchase it in specially opened cannabis clinics, the Swiss Cannabis Centers, and pharmacies. Additionally, a control group of 2,500 cannabis consumers will be studied, who will not have legal access during the study period.

The first Swiss Cannabis Centers opened in Zurich on May 2, 2024, at Konradstrasse 1 near Zurich's main train station, as well as in Winterthur and Schlieren. Both the trials and the participants are monitored by experts and scientists throughout the entire study: An independent research team from the University of Zurich and ETH Zurich is responsible for the study design, while physicians from Arud, Switzerland's largest center for addiction medicine, care for the participants.

All information about the project can be found at www.swisscannabis-research.ch